Open access
Sep 2026
Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson's disease.
Preclinical manufacturing strategy and results demonstrating efficacy in a PD rodent model and safety in a 9-month GLP toxicology study are reported.
A. Bratt-Leal, T. Gorba, Roy M. Williams et al.
· Cell Stem Cell · 0 citations